Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bacteremia: early-phase trial registry
2 of 12 indexed Bacteremia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 2 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Bacteremia: 12 US clinical trials tracked, 2 recruiting.
Bacteremia is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is T2 Biosystems, running 1 of these trials.
Enrollment posture brief
Registry condition bacteremia
OPEN 2 | RECR 17% | LATE 0 | EARLY 3 | RANK #1429 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)
Bacteremia lists 2 open slots (17% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bacteremia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bacteremia is recruiting below its size-band peers.
2 of 12 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Bacteremia trials is spread across many organizations.
T2 Biosystems accounts for 1 of 12 trials (8.3%). 12 distinct sponsors appear on at least one study for this condition label.
-
Typical Bacteremia enrolment sits around 1,354 participants.
Median target enrolment is 1,354 among the 12 trials that report a genuine target (sentinel values excluded). 2 of those (16.7%) plan for fewer than 100 participants.
-
Bacteremia splits between interventional and observational designs.
6 interventional and 6 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Reducing Risk for Infective Endocarditis
Wake Forest University Health Sciences
NCT05721781
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
Methodist Health System
NCT07486362
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
Henry Ford Health System
NCT05296590
Multicenter Blood Culture Quality Improvement
Vanderbilt University
NCT01413555
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
Emory University
NCT00965198
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
Sunnybrook Health Sciences Centre
NCT03005145
T2Bacteria Panel Pivotal Study
T2 Biosystems
NCT02535468
Virulence Determinants in S Aureus Bacteremia
Duke University
NCT00319826
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
University of British Columbia
NCT01867905
Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
Cook County Health
NCT00130221
Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
M.D. Anderson Cancer Center
NCT01321879
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
Genentech
NCT03162250
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Bacteremia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bacteremia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bacteremia page
12 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Bacteremia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- T2 Biosystems sponsors the most Bacteremia trials on record, review their full trial history before evaluating a specific study. See T2 Biosystems's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bacteremia condition card totals 12 registered trials; most-linked intervention Telavancin; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.